Nautilus Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- Nautilus Biotechnology's estimated annual revenue is currently $20.3M per year.
- Nautilus Biotechnology's estimated revenue per employee is $122,319
- Nautilus Biotechnology's total funding is $303.2M.
- Nautilus Biotechnology's current valuation is $550.1M. (January 2022)
Employee Data
- Nautilus Biotechnology has 166 Employees.
- Nautilus Biotechnology grew their employee count by 38% last year.
Nautilus Biotechnology's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, Chief Scientist | Reveal Email/Phone |
2 | Sr. VP, Operations, Nautilus Biotechnology | Reveal Email/Phone |
3 | Head Product Management | Reveal Email/Phone |
4 | VP Corporate Marketing and Communications | Reveal Email/Phone |
5 | Manager Aptamer Discovery | Reveal Email/Phone |
6 | Senior Scientist and Manager, Platform Integration Team | Reveal Email/Phone |
7 | Principal Scientist | Reveal Email/Phone |
8 | Scientist | Reveal Email/Phone |
9 | R&D Leader | Reveal Email/Phone |
10 | Bioinformatics Research Associate II | Reveal Email/Phone |
Nautilus Biotechnology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Nautilus Biotechnology?
Born from the foundersￃﾢ￢ﾂﾬ￢ﾄﾢ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. The extraordinary team at Nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. Nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.
keywords:N/A
$303.2M
Total Funding
166
Number of Employees
$20.3M
Revenue (est)
38%
Employee Growth %
$550.1M
Valuation
N/A
Accelerator
Nautilus Biotechnology News
Analysts expect Nautilus Biotechnology to post earnings of ($0.15) per share for the quarter. Persons that are interested in registering for the...
About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco...
About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco...
Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. (Nautilus Photo) Nautilus Biotechnology, a Seattle-based biotech startup led by Isilon co-founder Sujal Patel, is the latest company to go public using a special purpose acquisition company, or SPAC. The deal, announced M ...
Seattle-based Nautilus is combining with Arya III, a special purpose acquisition company (SPAC), which is a publicly traded entity formed as a vehicle for other companies to go public. The combined company, which will be run by Nautilus’s management, will have a valuation of about $900 million. ...
Other Companies in San Carlos
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $58.1M | 182 | -7% | N/A |
#2 | $52.3M | 190 | 14% | N/A |
#3 | $31.6M | 204 | 44% | N/A |
#4 | $34.8M | 223 | -26% | $173.2M |
#5 | $15M | 235 | 9% | N/A |